Pharmacelera has been awarded an SME Phase I grant from the European Commission for its MolPredict project. The EU received 2009 requests in the call where Pharmacelera submitted its proposal and it decided to support 257 small and medium-sized companies (SMEs) from 31 countries (a 12.8% acceptance rate) who aim to get their innovations faster…Read more
About: Enric Gibert
Recent Posts by Enric Gibert
The Spanish National Research Centre (CNIO) is a Spanish public institution focused on the research, diagnosis and treatment of cancer. The CNIO is positioned within the top 10 ranking of research centres dedicated to cancer research worldwide (Scimago; Nature Index) and covers the whole R+D+I process, from basic up to clinical research to translate their…Read more
After receiving the Seal-Of-Excellence from the European Union SME Instrument program under the umbrella of the H2020 framework, Pharmacelera has been awarded an Horizonte Pyme grant from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economía y Competitividad, agreement SME-2016-0854-10). “This grant will boost the development of our computing platform in the cloud to…Read more
Recent Comments by Enric Gibert
No comments by Enric Gibert yet.